Path 2

targeted cellular responses

CytoComm™ for Oncology

CytoComm™ is being designed to allow wireless monitoring of targeted cellular responses in chemotherapy patients. CytoComm™ intends to provide more data and higher quality data to the physician during the treatment of patients.

Current drug dosing calculations are based on a patient’s height and weight, rather than actual, real-time physiological conditions. By sensing levels of medication and other markers within the patient, CytoComm™ is being built to provide real-time information from the patient’s own body. CytoComm™, as a result, should drive drug dosing for relatively constant levels of chemotherapy medication to be dispensed to the patient.


  • More Data, More Often
    CytoComm™ is built to provide real-time patient data to clinicians, available 24 hours a day, 7 days a week.
  • Personalized Dosing
    CytoComm™ is designed to allow doctors to tailor a personalized treatment plan, based on real-time physiological conditions of a patient.
  • Reduced Toxicity
    With a finely tuned, personalized treatment plan, CytoComm™ should help to reduce toxicity and improve personal well-being.